Intralesional photodynamic therapy: A comment on 'pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy' by Gerritsen et al.

Dermatology

Volumn 220, Issue 1, 2010, Pages 44-45

  Torchia, Daniele ^a,b   Cappugi, Pietro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

5 Aminolevulinic acid; Photodynamic therapy, intralesional

Indexed keywords

AMINOLEVULINIC ACID; HYPERICIN; MACROGOL; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; TETRAKIS(4 SULFOPHENYL)PORPHINE;

ACNE VULGARIS; BASAL CELL CARCINOMA; BREAST CANCER; CONDYLOMA; FLUORESCENCE; HUMAN; LETTER; PAGET SKIN DISEASE; PATIENT SAFETY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN METASTASIS; SQUAMOUS CELL CARCINOMA; THERAPY EFFECT;

AMINOLEVULINIC ACID; HUMANS; INJECTIONS, INTRALESIONAL; PHOTOCHEMOTHERAPY; PROTOPORPHYRINS; SKIN NEOPLASMS;

EID: 76649125522     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000264668     Document Type: Letter

References (11)

1. Gerritsen MJP, Smits T, Kleinpenning MM, van de Kerkhof PCM, van Erp PEJ: Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology 2009; 218: 193-202.
2. Lapes M, Petera J, Jirsa M: Photodynamic therapy of cutaneous metastases of breast cancer after local application of meso-tetra-(para-sulphophenyl)- porphin (TPPS4). J Photochem Photobiol B 1996; 36: 205-207.
3. Fink-Puches R, Wolf P, Kerl H: Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light. Arch Dermatol 1997; 133: 1494-1495.
4. Alecu M, Ursaciuc C, Hãlãlãu F, Coman G, Merlevede W, Waelkens E, de Witte P: Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin. Anticancer Res 1998; 18: 4651-4654.
5. Henta T, Itoh Y, Kobayashi M, Ninomiya Y, Ishibashi A: Photodynamic therapy for inoperable vulval Paget's disease using delta-aminolaevulinic acid: successful management of a large skin lesion. Br J Dermatol 1999; 141: 347-349.
6. Cappugi P, Mavilia L, Campolmi P, Reali EF, Mori M, Rossi R: New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid. J Chemother 2004; 16: 491-493.
7. Chapas A, Zeltser R, Geronemus R, Gilchrest B: Intralesional photodynamic therapy of nonmelanoma skin cancer. Lasers Surg Med 2006; 38(suppl 18):27.
8. Ryou JH, Lee SJ, Park YM, Kim HO, Kim HS: Acne-photodynamic therapy with intra-lesional injection of 5-aminolevulinic acid. Photodermatol Photoimmunol Photomed 2009; 25: 57-58.
9. Peng Q, Warloe T, Moan J, Heyerdahl H, Steen HB, Nesland JM, Giercksky KE: Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol 1995; 62: 906-913.
10. Torchia D: Photodynamic therapy on intact and/or thick skin. Clin Exp Dermatol 2009; 34:e327.
11. Ross EV, Romero R, Kollias N, Crum C, Anderson RR: Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment. Br J Dermatol 1997; 137: 736-742.